| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 130.10M | 90.50M | 65.80M | 73.70M | 75.00M |
| Gross Profit | 66.40M | 56.20M | 44.90M | 46.40M | 47.10M |
| EBITDA | 52.50M | 44.80M | 18.60M | 37.80M | 37.50M |
| Net Income | 31.70M | 23.70M | 3.00M | -16.80M | 7.00M |
Balance Sheet | |||||
| Total Assets | 1.02B | 1.05B | 759.60M | 781.50M | 819.10M |
| Cash, Cash Equivalents and Short-Term Investments | 115.50M | 61.30M | 132.80M | 108.60M | 82.80M |
| Total Debt | 517.30M | 510.60M | 372.20M | 373.40M | 371.50M |
| Total Liabilities | 564.20M | 564.00M | 398.50M | 402.90M | 405.00M |
| Stockholders Equity | 457.60M | 490.10M | 361.10M | 378.60M | 414.10M |
Cash Flow | |||||
| Free Cash Flow | 19.60M | 18.70M | 16.60M | 24.00M | 34.90M |
| Operating Cash Flow | 37.20M | 28.40M | 22.70M | 27.00M | 47.50M |
| Investing Cash Flow | 85.10M | -67.80M | 23.60M | 18.80M | 239.80M |
| Financing Cash Flow | -68.10M | -32.10M | -22.10M | -20.00M | -355.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £428.64M | 8.81 | 11.57% | 7.17% | 9.07% | 21.13% | |
71 Outperform | £161.53M | 13.16 | 7.33% | 7.43% | -10.95% | -30.09% | |
71 Outperform | £1.05B | 17.05 | 5.56% | 7.70% | -4.33% | -11.83% | |
69 Neutral | £1.82B | 7.62 | 11.77% | 4.33% | 73.32% | ― | |
68 Neutral | £315.26M | 10.12 | 6.98% | 9.66% | 43.76% | 12.54% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
60 Neutral | £294.31M | 100.32 | 0.80% | 8.16% | 5.75% | ― |